A mechanistically novel peptide agonist of the IL-7 receptor that addresses limitations of IL-7 cytokine therapy
W. J. Dower, A. I. Park, A. V. Bakker, S. E. Cwirla, P. Pongtornpipat, B. M. Williams, P. Joshi, B. A. Baxter, M. C. Needels, R. W. Barrett
This paper introduces a novel peptide agonist of the IL-7 receptor that mimics IL-7's biological activity but has improved therapeutic properties and reduced immunogenicity.
bioRxiv · May 24, 2023Immunology